Comparative safety of the BNT162b2 messenger RNA COVID-19 vaccine vs other approved vaccines in children younger than 5 years
N Toepfner, WCG von Meißner, C Strumann… - JAMA network …, 2022 - jamanetwork.com
Importance SARS-CoV-2 vaccines are authorized for use in most age groups. The safety of
SARS-CoV-2 vaccines is unknown in children younger than 5 years. Objective To
retrospectively evaluate the safety of the BNT162b2 vaccine used off-label in children
younger than 5 years compared with the safety of non–SARS-CoV-2 vaccines in the same
sample. Design, Setting, and Participants This investigator-initiated retrospective cohort
study included parents or caregivers who registered children for SARS-CoV-2 vaccination in …
SARS-CoV-2 vaccines is unknown in children younger than 5 years. Objective To
retrospectively evaluate the safety of the BNT162b2 vaccine used off-label in children
younger than 5 years compared with the safety of non–SARS-CoV-2 vaccines in the same
sample. Design, Setting, and Participants This investigator-initiated retrospective cohort
study included parents or caregivers who registered children for SARS-CoV-2 vaccination in …